Back to medications
Medication monograph

semaglutide

GLP-1 Receptor AgonistsAntidiabeticsBlood Glucose Lowering AgentsGLP-1 AgonistsIncretin MimeticsIncretin Mimetics

Clinical reference

Product monograph

OZEMPIC- semaglutide injection, solution

RYBELSUS- oral semaglutide tablet

Brands & formulations

Family members

OZEMPIC

Marketed
1.34 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

OZEMPIC

Marketed
1.34 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

RYBELSUS

Marketed
3 MGORALTABLET[ "semaglutide" ]
Product monograph

RYBELSUS

Marketed
7 MGORALTABLET[ "semaglutide" ]
Product monograph

RYBELSUS

Marketed
14 MGORALTABLET[ "semaglutide" ]
Product monograph

WEGOVY

Marketed
1 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

WEGOVY

Marketed
2 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

WEGOVY

Marketed
4 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

WEGOVY

Marketed
6.8 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

WEGOVY

Marketed
9.6 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

OZEMPIC

Marketed
0.68 MGSUBCUTANEOUSSOLUTION[ "semaglutide" ]
Product monograph

Classification

Chemical class
GLP-1 Receptor Agonists
Clinical class
Antidiabetics
Banks class
Blood Glucose Lowering Agents, GLP-1 Agonists, Incretin Mimetics
AHFS family
Incretin Mimetics